The JSE was weaker on Tuesday, with its global peers mixed as investors digest another Covid-19 vaccine announcement, while new restrictions are being implemented.

The stock markets received a boost on Monday after Moderna said that its preliminary phase 3 trial data showed its Covid-19 vaccine was more than 94% effective. Moderna’s announcement comes a week after Pfizer and BioNTech announced their vaccine trial results...

BL Premium

This article is reserved for our subscribers.

A subscription helps you enjoy the best of our business content every day along with benefits such as exclusive Financial Times articles, ProfileData financial data, and digital access to the Sunday Times and Sunday Times Daily.

Already subscribed? Simply sign in below.

Questions or problems? Email or call 0860 52 52 00. Got a subscription voucher? Redeem it now